Parallel importing of pharmaceuticals reduces the value of pharmaceuticals by introducing competitors; Journeys settlement in Article 6 states that this follow cannot be challenged underneath the WTO dispute settlement machine
Parallel importing of pharmaceuticals reduces the value of pharmaceuticals by introducing competitors; Journeys settlement in Article 6 states that this follow cannot be challenged underneath the WTO dispute settlement machine